Safety and Efficacy of RX-af01 Combined With PD-1 Antibody

Clinical trial NCT05576961 · UNKNOWN

Trial details

NCT number: NCT05576961
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Immune Checkpoint Inhibitor Intestinal Flora

Start date: 2022-09-15
Primary completion: 2024-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.